Posted: March 18, 2020

Letter of Intent due 30 days prior to application; Application due June 29, 2020

The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.

Read full solicitation here

Office of Grants and Contracts

Address

107 Ag Administration Building
University Park, PA 16802